AMY ANDUJAR: Open Payments
NPI 1659448793 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 26 payments from 12 companies in 2025. Trend: 2023 $742 · 2024 $321 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $154 |
| PFIZER INC. | 1 | $107 |
| Novo Nordisk Inc | 5 | $98 |
| Corcept Therapeutics | 2 | $69 |
| Exact Sciences Corporation | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ABBVIE INC. | 2 | $40 |
| Inari Medical, Inc. | 1 | $28 |
Products named: Auvelity, NURTEC ODT, Korlym, Ozempic, Kerendia, Wegovy, QULIPTA, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
